Journal Summary - Discover more summaries and articles from M3 India

Oncology

Choose Topic

Exploration of differentially expressed plasma proteins in patients with lung adenocarcinoma using iTRAQ-coupled 2D LC-MS/MS

The Clinical Respiratory Journal | Jan 29, 2018 General Oncology Lung/Thoracic Oncology

Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004–2013)

Urologic Oncology: Seminars and Original Investigations | Jan 28, 2018 General Oncology Renal/Urologic

T-cell papulosis associated with B-cell malignancy: A distinctive clinicopathologic entity

Journal of the European Academy of Dermatology and Venereology | Jan 28, 2018 General Oncology Leukemia/Lymphoma Dermatologic Oncology

Early chemotherapy intensification with escalated BEACOPP in patients with advanced-stage Hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two ABVD cycles: Long-term results of the GITIL/FIL HD 0607 Trial

Journal of Clinical Oncology | Jan 27, 2018 General Oncology Leukemia/Lymphoma

Different toxicity of cetuximab and panitumumab in metastatic colorectal cancer treatment: A systematic review and meta-analysis

Oncology | Evidence based | Jan 27, 2018 Pharmacology/Therapy Colorectal Cancer/Polyps General Oncology

Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients

Clinical and Translational Oncology | Jan 27, 2018 General Oncology Pharmacology/Therapy Lung/Thoracic Oncology

Bevacizumab maintenance vs no maintenance during chemotherapy-free intervals in metastatic colorectal cancer: A randomized phase III trial (PRODIGE 9)

Journal of Clinical Oncology | Jan 26, 2018 Pharmacology/Therapy GI Oncology General Oncology Colorectal Cancer/Polyps

Continued excellent outcomes in previously untreated patients with follicular lymphoma after treatment with CHOP plus rituximab or CHOP plus ¹³¹I-tositumomab: Long-term follow-up of phase III randomized study SWOG-S0016

Journal of Clinical Oncology | Jan 26, 2018 Leukemia/Lymphoma Pharmacology/Therapy General Oncology

Epidemiologic evidence that excess body weight increases risk of cervical cancer by decreased detection of precancer

Journal of Clinical Oncology | Jan 26, 2018 General Oncology Gynecologic Oncology

Clinical evidence of prevention strategies for capecitabine-induced hand-foot syndrome

International Journal of Cancer | Jan 26, 2018 General Oncology Pharmacology/Therapy

« Prev 1 … 1098 1099 1100 1101 1102 … 1255 Next »

Exploration of differentially expressed plasma proteins in patients with lung adenocarcinoma using iTRAQ-coupled 2D LC-MS/MS

Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004–2013)

T-cell papulosis associated with B-cell malignancy: A distinctive clinicopathologic entity

Early chemotherapy intensification with escalated BEACOPP in patients with advanced-stage Hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two ABVD cycles: Long-term results of the GITIL/FIL HD 0607 Trial

Different toxicity of cetuximab and panitumumab in metastatic colorectal cancer treatment: A systematic review and meta-analysis

Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients

Bevacizumab maintenance vs no maintenance during chemotherapy-free intervals in metastatic colorectal cancer: A randomized phase III trial (PRODIGE 9)

Continued excellent outcomes in previously untreated patients with follicular lymphoma after treatment with CHOP plus rituximab or CHOP plus ¹³¹I-tositumomab: Long-term follow-up of phase III randomized study SWOG-S0016

Epidemiologic evidence that excess body weight increases risk of cervical cancer by decreased detection of precancer

Clinical evidence of prevention strategies for capecitabine-induced hand-foot syndrome

Fibrate Therapy: Understanding the Risks

Polycystic Ovary Syndrome: Management Strategies

Patients with IBS Have a Higher Risk of These Debilitating Disorders

Anaesthetic Management in Obese Patients

Lasers: A Boon in Paediatric Dentistry

Exploration of differentially expressed plasma proteins in patients with lung adenocarcinoma using iTRAQ-coupled 2D LC-MS/MS

Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004–2013)

T-cell papulosis associated with B-cell malignancy: A distinctive clinicopathologic entity

Early chemotherapy intensification with escalated BEACOPP in patients with advanced-stage Hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two ABVD cycles: Long-term results of the GITIL/FIL HD 0607 Trial

Different toxicity of cetuximab and panitumumab in metastatic colorectal cancer treatment: A systematic review and meta-analysis

Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients

Bevacizumab maintenance vs no maintenance during chemotherapy-free intervals in metastatic colorectal cancer: A randomized phase III trial (PRODIGE 9)

Continued excellent outcomes in previously untreated patients with follicular lymphoma after treatment with CHOP plus rituximab or CHOP plus 131I-tositumomab: Long-term follow-up of phase III randomized study SWOG-S0016

Epidemiologic evidence that excess body weight increases risk of cervical cancer by decreased detection of precancer

Clinical evidence of prevention strategies for capecitabine-induced hand-foot syndrome

Fibrate Therapy: Understanding the Risks

Polycystic Ovary Syndrome: Management Strategies

Patients with IBS Have a Higher Risk of These Debilitating Disorders

Anaesthetic Management in Obese Patients

Lasers: A Boon in Paediatric Dentistry

Select Specialty

Select Topic

Continued excellent outcomes in previously untreated patients with follicular lymphoma after treatment with CHOP plus rituximab or CHOP plus ¹³¹I-tositumomab: Long-term follow-up of phase III randomized study SWOG-S0016